Gaudium IVF and Women Health Limited has announced its IPO price band at Rs 75–79 per share. The issue, comprising a fresh offering of equity shares, opens for subscription on February 24, 2026, and closes on February 26, 2026. Listing is expected on BSE and NSE by March 3, 2026.
Gaudium IVF and Women Health Limited, a leading fertility and women’s healthcare provider, is entering the capital markets with its maiden public offering. The IPO will be a book-built issue, with proceeds earmarked for expanding IVF centers, enhancing medical infrastructure, and strengthening working capital.
The company has shown steady growth in revenue and patient base, driven by rising demand for fertility treatments and specialized women’s healthcare services. Analysts believe the IPO could attract strong interest from retail investors, given the affordable price band and the sector’s long-term growth potential.
Interactive Financial Services Ltd. is acting as the book-running lead manager, while Bigshare Services Pvt. Ltd. will serve as registrar. The allotment is expected to be finalized on February 27, 2026, with listing scheduled for March 3, 2026.
Key Highlights
-
IPO price band set at Rs 75-79 per share
-
Subscription window from February 24 to February 26, 2026
-
Allotment on February 27, listing on March 3, 2026
-
Proceeds to fund IVF center expansion and infrastructure upgrades
-
Lead manager: Interactive Financial Services Ltd.
-
Registrar: Bigshare Services Pvt. Ltd.
Sources: Moneycontrol, IPO Watch, Economic Times